Email not displaying properly? View email in your browser
logo
Newsletter Vol.45
November 2026
Advertise With Us Get Published Join Our Advisory Board Editorial calendar  
 
banner image
 
Latest EDITION
» Micronisation in Early Drug Development
» 3D Printing for Capsule Filling
» Oligonucleotide Therapeutic
» Isotopic Labelling for Drug Development
SUBSCRIBE
Pharma Focus Europe Magazine - Latest Edition
banner image
 

Articles

Post-Trial Clinical Research: Responsibilities and Dissemination

The completion of a clinical trial marks the end of data collection but not the end of research responsibility. The scientific and ethical value of a trial is realized only...

 

INTERVIEW

Applied Artificial Intelligence for Drug Discovery

Applied Artificial Intelligence for Drug Discovery (Springer, 2026) offers a comprehensive, forward looking overview of how AI, machine learning, and deep learning...

banner image
 

NEWS

FDA Approves Roche’s Wilserdly for Advanced Breast Cancer

Roche has received approval from the US Food and Drug Administration (FDA) for Wilserdly (giredestrant) in combination with everolimus to treat adults with oestrogen...

banner image
 

PROJECTS

Bayer Invests $2.2 Billion in New Ohio Pharmaceutical Facility

Bayer is investing US$2.2 billion to establish a new pharmaceutical manufacturing facility in New Albany, Ohio, as part of its strategy to strengthen production capacity...

 

PRESS RELEASE

Asimov and Emergent BioSolutions Partner on Ebola Antibodies

Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, and Emergent Biosolutions, a leading global public health company, today...

LATEST APPOINTMENTS

 
Ann Gallo

Keli Walbert

Hemab Therapeutics Appoints Keli Walbert to Its Board of Directors

 

Rajiv De Silva

Cipher Pharmaceuticals Appoints Rajiv De Silva to Strengthen Board Leadership

 

Sonia Quaratino

Engitix Appoints Sonia Quaratino as EVP Chief Medical Officer to Advance Clinical Development

 
Other Appointments →

TECHNO TRENDS

Juniper Biosciences Receives FDA Breakthrough Therapy Designation

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Juniper Biosciences’ JBS-003 (18F-fluoromisonidazole, or FMISO) for identifying...

banner image
 

RESEARCH INSIGHTS

CAVE-Onc: AI-Powered Validation of CDISC Oncology Submissions

Clinical trial data submitted to regulatory authorities must conform to the Study Data Tabulation Model (SDTM) standards maintained by the Clinical Data Interchange...

 

EVENTS

 
Events Image
Post your Event
Pharmtech & Ingredients 2026
November 24 - 27 | Russia
 
BioPharma Deals Conference 2026
November 24 - 25 | Munich, Germany
 
What’s Next for Pharma Marketing in 2027
November 25 - 25 | Munich, Germany
www.pharmafocuseurope.com
Facebook LinkedIn X